03.26.2026
Latest News
Iktos announces a new partnership with Chemspeed to help pharmaceutical companies unlock new possibilities in automated chemical research
Iktos, a pioneer in artificial intelligence (AI) and robotics for drug discovery, today announced a collaboration with Chemspeed Technologies (a Bruker company), a Swiss leader in laboratory automation systems, to offer pharmaceutical partners a solution combining advanced synthesis planning and orchestration AI software with robotics for chemical synthesis execution. The partnership aims to help pharmaceutical companies accelerate discovery programs, increase laboratory productivity, and unlock new possibilities in automated chemical research.
Press releases and recognitions
Press articles
Iktos featured by AWS Pioneers Project: Stories behind Europe's innovative breakthroughs
Across Europe, innovators are reinventing what technology can do—for people and for the planet. From mapping the ocean to understanding how the human body works, these pioneers use cloud infrastructure, AI agents, and generative AI from AWS to solve humanity's toughest challenges, impacting millions of lives and protecting vital ecosystems.
Founded in 2016, Iktos is one of a handful of firms that saw the early potential of AI in drug discovery.
“It was kind of a revolution in our minds, saying that maybe you can use AI to optimise molecules,” explains Nicolas Do Huu, co-founder and CTO of Iktos.
Press Contact
PR Agency
For any communication need please contact PRLab
Mail : dwain@prlab.co
Tel. : +31 202 443 748
